Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Dow
McKinsey
AstraZeneca
Moodys

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Astaxanthin

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Astaxanthin?

Astaxanthin is an investigational drug.

There have been 4 clinical trials for Astaxanthin. The most recent clinical trial was a Phase 2 trial, which was initiated on February 1st 2011.

The most common disease conditions in clinical trials are Stroke, Hypercholesterolemia, and Retinal Diseases. The leading clinical trial sponsors are Indonesia University, University Hospital of Ferrara, and Sheba Medical Center.

There is one US patent protecting this investigational drug and twelve international patents.

Recent Clinical Trials for Astaxanthin
TitleSponsorPhase
Nutraceutical in Cardiovascular Primary PreventionUniversity Hospital of FerraraPhase 2
Physiological and Molecular Influences of Astaxanthin Supplementation on Heat Strain in HumansSheba Medical CenterN/A
Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic RetinopathyInstituto Mexicano del Seguro SocialPhase 2

See all Astaxanthin clinical trials

Clinical Trial Summary for Astaxanthin

Top disease conditions for Astaxanthin
Top clinical trial sponsors for Astaxanthin

See all Astaxanthin clinical trials

US Patents for Astaxanthin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Astaxanthin   Start Trial Method for increasing the health condition of crustaceans in aquaculture, survival rate and pigmentation   Start Trial
Astaxanthin   Start Trial Ready-to-use, stable emulsion BASF SE (Ludwigshafen am Rhein, DE)   Start Trial
Astaxanthin   Start Trial Seaweed-derived cosmetic compositions Skinergistics Clinical Skin Solutions Inc. (Vancouver, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Boehringer Ingelheim
Express Scripts
McKinsey
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.